The HCPLive Gastroenterology condition center page is a comprehensive resource for clinical news and insights on digestive and GI conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for C difficile, IBS and IBD, Crohn's disease, and more.
November 22nd 2024
The supplemental Biologics License Application is supported by the phase 3 ASTRO study of guselkumab SC induction therapy in ulcerative colitis.
Despite Cost, Medicaid Programs Spending Heavily on Hep C Drug
Expensive and worth it. That's the verdict from Medicaid programs across the US when it comes to the new hepatitis C antivirals. State spending figures are available in a study published as a letter in the New England Journal of Medicine.
Drop That Big Mac and Check Out This One-Hour Timeline of Unhealthy Effects
September 24th 2015Devoted soda drinkers began to lose their minds when an infographic outlining the harmful effects a single can of Coca-Cola has on the body in one hour began circulating the Internet. Now a new infographic has revealed what a Big Mac from McDonald's can do to the body in the same amount of time.
Advanced Colorectal Cancer Treatment Approved
The US Food and Drug Administration (FDA) has approved the oral nucleoside TAS-102 (Lonsurf/ Taiho Pharmaceutical Co., Ltd) to treat patients with advanced colorectal cancer (CRC) who had not been responding to other treatments.
Study Shows Increase in Hepatitis C Rate Among Some HIV-Positive Men
September 18th 2015Researchers conducted an analysis of studies that spanned more than two decades and found that outbreaks of sexually transmitted hepatitis C is increasing among men who are HIV positive and have sex with other men.
Hepatitis C Virus Enzyme Could Provide Novel Drug Target
September 18th 2015Scientists in Italy say they have gained new insight into how the hepatitis C virus replicates as a result of studying the behavior of a key enzyme and creating a computer model that shows how it interacts with the viral genome.
New Procedure Successfully Controls Symptoms of Gastroesophageal Reflux Disease
September 17th 2015The LINX Reflux Management System was recently shown to successfully control reflux-related symptoms in patients with gastroesophageal reflux disease (GERD), reducing their need to continue treatment with proton pump inhibitors (PPIs) and other acid-suppression medications.
State Governments Responding to Curative but Costly Hepatitis C Medications
Several states – including Delaware and Georgia – are beginning to take action to increase diagnosis and access to treatment for patients with hepatitis C. The news comes in the wake of several studies showing that patients are often denied treatment. In addition, a highly regarded health council recently asked the White House to remove the restrictions that Medicaid often places on costly treatments that effectively amount to a cure for the potentially deadly disease.
Fecal Transplantation Can Slay Superbugs
Fecal microbiota transplantation (FMT), already shown to be effective for Clostridium difficile treatment, has been found to eradicate two of the most common antibiotic-resistant hospital superbugs: vancomycin-resistant Enterococcus faecium (VRE) and multidrug-resistant Klebsiella pneumoniae.
Health Experts to White House: "Widen Access to Hepatitis C Medications"
Experts from the Public Health Service and President Obama's Advisory Council on HIV/AIDS have asked the administration in a letter to widen access to new, high-cost medications that successfully treat hepatitis C.
Caffeine Addicted Colon Cancer Patients May See Improvements in Survival Rates
Caffeine addicts, rejoice. A recent study concluded that regularly consuming caffeinated coffee could potentially help inhibit the return of colon cancer post-treatment, eventually improving the chance for a cure.
Diagnosing and Treating Exocrine Pancreatic Insufficiency in Patients with Celiac Disease
New research concludes that the association between celiac disease and exocrine pancreatic insufficiency (EPI) is strong enough that physicians should check for EPI when celiac patients suffer malnutrition or gastric distress despite adherence to prescribed diets.
Patients with the cystic fibrosis transmembrane conductance regulator gating mutation G551D have insufficient ion transport due to reduced channel-open probability. New information suggests that increased ion transport reduces disease burden in the pancreas, which prevents cystic fibrosis patients from digesting food properly and leads to exocrine pancreatic insufficiency in up to 90% of all cases.
Bacteria Band Together to Fight Infection
August 12th 2015In a recent study, researchers assessed seven groups of mice that were given various antibiotics and then exposed to C. diff spores. Using advanced genetic analysis, the team determined which bacteria survived the antibiotic challenge, as well as what factors allowed C. diff to effectively infect the mice.